JAMES C. MOMTAZEE

Insider Reports History

Location
Menlo Park, CA
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for James C Momtazee
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES C. MOMTAZEE:

Company Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Pharma, Inc. Director Common Stock 95,080 $3,122,427 $32.84 20 Jun 2025 Direct
Roivant Sciences Ltd. Director Common Shares 109,030 $2,505,509 $22.98 20 Jan 2026 Direct
Roivant Sciences Ltd. Director Stock Option (Right to Buy) 33,726 10 Sep 2025 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 8,425 20 Jun 2025 Direct
PRA Health Sciences, Inc. Director Common Stock 0 $169.75 01 Jul 2021 Direct

Insider Reports Filed by JAMES C. MOMTAZEE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ROIV Roivant Sciences Ltd. 20 Jan 2026 2 -$2,804 4 Director 22 Jan 2026, 21:00
ROIV Roivant Sciences Ltd. 20 Oct 2025 2 -$2,803 4 Director 22 Oct 2025, 21:01
ROIV Roivant Sciences Ltd. 10 Sep 2025 3 -$45,193 4 Director 12 Sep 2025, 21:00
ROIV Roivant Sciences Ltd. 17 Jul 2025 2 -$2,808 4 Director 21 Jul 2025, 21:00
BBIO BridgeBio Pharma, Inc. 20 Jun 2025 2 $0 4 Director 24 Jun 2025, 18:57
ROIV Roivant Sciences Ltd. 17 Apr 2025 2 -$2,801 4 Director 21 Apr 2025, 21:00
ROIV Roivant Sciences Ltd. 23 Jan 2025 2 -$3,430 4 Director 27 Jan 2025, 21:00
ROIV Roivant Sciences Ltd. 21 Oct 2024 1 $0 4 Director 23 Oct 2024, 21:00
ROIV Roivant Sciences Ltd. 12 Sep 2024 1 -$37,039 4 Director 16 Sep 2024, 21:00
ROIV Roivant Sciences Ltd. 10 Sep 2024 2 $0 4 Director 12 Sep 2024, 21:00
ROIV Roivant Sciences Ltd. 23 Jul 2024 1 $0 4 Director 25 Jul 2024, 21:00
BBIO BridgeBio Pharma, Inc. 21 Jun 2024 1 $0 4 Director 25 Jun 2024, 17:39
ROIV Roivant Sciences Ltd. 24 Apr 2024 2 -$3,194 4 Director 26 Apr 2024, 21:01
ROIV Roivant Sciences Ltd. 19 Jan 2024 1 $0 4 Director 23 Jan 2024, 21:00
ROIV Roivant Sciences Ltd. 16 Oct 2023 2 -$7,076 4 Director 18 Oct 2023, 21:30
ROIV Roivant Sciences Ltd. 18 Sep 2023 1 -$75,420 4 Director 20 Sep 2023, 21:33
ROIV Roivant Sciences Ltd. 12 Sep 2023 2 $0 4 Director 14 Sep 2023, 21:31
ROIV Roivant Sciences Ltd. 03 Jul 2023 1 $0 4 Director 06 Jul 2023, 21:30
BBIO BridgeBio Pharma, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:22
ROIV Roivant Sciences Ltd. 03 Apr 2023 1 $0 4 Director 05 Apr 2023, 21:31
ROIV Roivant Sciences Ltd. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 20:30
ROIV Roivant Sciences Ltd. 31 Oct 2022 1 $0 4 Director 02 Nov 2022, 17:57
ROIV Roivant Sciences Ltd. 15 Sep 2022 2 $0 4 Director 19 Sep 2022, 21:53
ROIV Roivant Sciences Ltd. 20 Jul 2022 1 $0 4 Director 25 Jul 2022, 06:06
BBIO BridgeBio Pharma, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:32
BBIO BridgeBio Pharma, Inc. 29 Dec 2021 1 +$1,160,000 4 Director 03 Jan 2022, 18:47
ROIV Roivant Sciences Ltd. 01 Oct 2021 0 $0 3 Director 01 Oct 2021, 17:41
/report/000089924321038834-momtazee-james-c-2021-09-30 Montes Archimedes Acquisition Corp 30 Sep 2021 0 $0 4 Chief Executive Officer, Director, 10%+ Owner 04 Oct 2021, 17:13
/report/000110465921088352-momtazee-james-c-2021-07-01 PRA Health Sciences, Inc. 01 Jul 2021 1 $0 4 Director 01 Jul 2021, 17:36
BBIO BridgeBio Pharma, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 19:21
/report/000110465921076355-momtazee-james-c-2021-06-01 PRA Health Sciences, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 16:04